| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.47B | +6.5% | +20.4% |
| R&D Expense | $862.0M | +2.6% | +11.4% |
| SG&A Expense | $1.18B | +76.8% | +87.8% |
| Operating Income | $1.11B | -23.2% | +4.9% |
| Pre-tax Income | $2.62B | +74.2% | -5.4% |
| Income Tax | -$4.05B | -2949.3% | -2660.8% |
| Net Income | $6.63B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.43B | +31.0% | +37.1% |
| Short-term Investments | $654.0M | -29.8% | -77.5% |
| Accounts Receivable | $3.77B | +0.1% | +1.5% |
| Current Assets | $15.14B | +7.3% | -1.3% |
| Total Assets | $63.34B | +13.2% | +34.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.22B | — | — |
| Capital Expenditures | $261.0M | — | — |
| Investing Cash Flow | -$1.95B | — | — |
| Financing Cash Flow | -$2.60B | — | — |
| Free Cash Flow | $6.96B | — | — |
| +389.0% |
| +153.7% |
| EPS (Basic) | $3.18 | +389.2% | +156.5% |
| EPS (Diluted) | $3.11 | +393.7% | +159.2% |
| $13.12B |
| +3.4% |
| +21.1% |
| Long-term Debt | $10.62B | +10.8% | -3.4% |
| Total Liabilities | $34.19B | +5.7% | +11.8% |
| Stockholders' Equity | $28.13B | +24.5% | +90.4% |